Cost-effectiveness of the treatment and prevention of osteoporosis—a review of the literature and a reference model

Author： Zethraeus N. Borgström F. Ström O. Kanis J. Jönsson B.

ISSN： 0937-941X

Source： Osteoporosis International, Vol.18, Iss.1, 2007-01, pp. : 9-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women

By Kanis J. Borgstrom F. Johnell O. Jonsson B.

Osteoporosis International, Vol. 15, Iss. 11, 2004-11 ,pp. : 862-871

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis

By Jönsson B. Ström O. Eisman J. Papaioannou A. Siris E. Tosteson A. Kanis J.

Osteoporosis International, Vol. 22, Iss. 3, 2011-03 ,pp. : 967-982

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis

By Beukelman T. Saag K. Curtis J. Kilgore M. Pisu M.

Osteoporosis International, Vol. 21, Iss. 9, 2010-09 ,pp. : 1573-1584

Springer Publishing Company

Access to resources Recommend Favorite

The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden

By Zethraeus N. Ström O. Borgström F. Kanis J. Jönsson B.

Osteoporosis International, Vol. 19, Iss. 6, 2008-06 ,pp. : 819-827

Springer Publishing Company

Access to resources Recommend Favorite

Engaging hepatitis C infected patients in cost‐effectiveness analyses: A literature review

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 774-781

John Wiley & Sons Inc

Access to resources Recommend Favorite